Literature DB >> 27254088

Epidemiology of Injection Drug Use: New Trends and Prominent Issues.

Élise Roy1, Nelson Arruda2, Julie Bruneau3, Didier Jutras-Aswad4.   

Abstract

After more than 30 years of research, numerous studies have shown that injection drug use is associated with a wide range of adverse health outcomes such as drug overdoses, drug-related suicidal behaviours, comorbid psychiatric disorders, bloodborne pathogens and other infectious diseases, and traumas. This review explores new trends and prominent issues associated with injection drug use. The dynamic nature of injection drug use is underlined by examining its recent trends and changing patterns in Canada and other "high-income countries." Three research topics that could further contribute to the development of comprehensive prevention and intervention strategies aimed at people who inject drugs are also discussed: risk behaviours associated with the injection of prescription opioids, binge injection drug use, and mental health problems as determinants of injection risk behaviours.
© The Author(s) 2016.

Entities:  

Keywords:  drug trends; drug use patterns; injection drug use; injection risk behaviours

Mesh:

Year:  2016        PMID: 27254088      PMCID: PMC4813418          DOI: 10.1177/0706743716632503

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  83 in total

1.  Distributive syringe sharing among young adult injection drug users in five U.S. cities.

Authors:  Elizabeth T Golub; Steffanie A Strathdee; Susan L Bailey; Holly Hagan; Mary H Latka; Sharon M Hudson; Richard S Garfein
Journal:  Drug Alcohol Depend       Date:  2007-03-29       Impact factor: 4.492

Review 2.  Polysubstance use: diagnostic challenges, patterns of use and health.

Authors:  Jason P Connor; Matthew J Gullo; Angela White; Adrian B Kelly
Journal:  Curr Opin Psychiatry       Date:  2014-07       Impact factor: 4.741

3.  Estimating the size of hard-to-reach populations: a novel method using HIV testing data compared to other methods.

Authors:  C P Archibald; G C Jayaraman; C Major; D M Patrick; S M Houston; D Sutherland
Journal:  AIDS       Date:  2001-04       Impact factor: 4.177

4.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

5.  Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users.

Authors:  Jennifer R Havens; Michelle R Lofwall; Simon D W Frost; Carrie B Oser; Carl G Leukefeld; Richard A Crosby
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

6.  Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.

Authors:  Kevin J P Craib; Patricia M Spittal; Evan Wood; Nancy Laliberte; Robert S Hogg; Kathy Li; Katherine Heath; Mark W Tyndall; Michael V O'Shaughnessy; Martin T Schechter
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

7.  Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics.

Authors:  Jon E Zibbell; Rachel Hart-Malloy; John Barry; Lillian Fan; Colleen Flanigan
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

8.  "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.

Authors:  Lynne Leonard; Emily DeRubeis; Linda Pelude; Emily Medd; Nick Birkett; Joyce Seto
Journal:  Int J Drug Policy       Date:  2007-05-01

Review 9.  Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs).

Authors:  Kenneth R Conner; Martin Pinquart; Paul R Duberstein
Journal:  Addiction       Date:  2008-02-04       Impact factor: 6.526

10.  Problematic use of prescription-type opioids prior to heroin use among young heroin injectors.

Authors:  Robin A Pollini; Caleb J Banta-Green; Jazmine Cuevas-Mota; Mitcheal Metzner; Eyasu Teshale; Richard S Garfein
Journal:  Subst Abuse Rehabil       Date:  2011-10
View more
  14 in total

Review 1.  The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?

Authors:  Stine Bordier Høj; Nanor Minoyan; Andreea Adelina Artenie; Jason Grebely; Julie Bruneau
Journal:  Can Liver J       Date:  2018-07-17

2.  Psychiatric Disorders and HIV Drug Risk Behaviors Among Individuals Under Community Correctional Supervision.

Authors:  Caitlin Wolford-Clevenger; Michelle L Sisson; Samantha P Schiavon; Mark Rynda; Karen L Cropsey
Journal:  J Correct Health Care       Date:  2021-12-14

3.  Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia.

Authors:  Anneli Uusküla; David M Barnes; Mait Raag; Ave Talu; Susan Tross; Don C Des Jarlais
Journal:  Drug Alcohol Depend       Date:  2018-05-08       Impact factor: 4.492

4.  Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.

Authors:  Brendan Jacka; Sarah Larney; Louisa Degenhardt; Naveed Janjua; Stine Høj; Mel Krajden; Jason Grebely; Julie Bruneau
Journal:  Am J Public Health       Date:  2019-11-14       Impact factor: 9.308

5.  Geographic Differences and Social Determinants of Health Among People With HIV Attributed to Injection Drug Use, United States, 2017.

Authors:  Chan Jin; Ndidi Nwangwu-Ike; Zanetta Gant; Shacara Johnson Lyons; Anna Satcher Johnson
Journal:  Public Health Rep       Date:  2021-04-21       Impact factor: 3.117

6.  Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis.

Authors:  Jin Yang; Yunquan Zhang; Lisha Luo; Runtang Meng; Chuanhua Yu
Journal:  Int J Environ Res Public Health       Date:  2018-01-22       Impact factor: 3.390

7.  Transition from First Drug Use to Regular Injection among People Who Inject Drugs in Iran.

Authors:  Masoomeh Koozegar; Armita Shahesmaeili; Mehdi Noroozi
Journal:  Addict Health       Date:  2018-01

8.  A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk.

Authors:  Katherine J Kasper; Iswarya Manoharan; Brian Hallam; Charlotte E Coleman; Sharon L Koivu; Matthew A Weir; John K McCormick; Michael S Silverman
Journal:  PLoS One       Date:  2019-08-09       Impact factor: 3.240

9.  Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model.

Authors:  Alastair Heffernan; Graham S Cooke; Shevanthi Nayagam; Mark Thursz; Timothy B Hallett
Journal:  Lancet       Date:  2019-01-29       Impact factor: 202.731

10.  Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.

Authors:  Kelsey Ragan; Anjali Pandya; Tristan Holotnak; Katrina Koger; Neil Collins; Mark G Swain
Journal:  Can J Gastroenterol Hepatol       Date:  2020-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.